Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• MillerKDSiegelRLLinCCCancer treatment and survivorship statistics, 2016CA Cancer J Clin201666427128927253694
   PubMed Web of Science ®Google Scholar
• MakkerVHensleyMLZhouQIasonosAAghajanianCATreatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009Int J Gynecol Cancer201323592993423598889
   PubMed Web of Science ®Google Scholar
• ItoKUtsunomiyaHNiikuraHYaegashiNSasanoHInhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancerMol Cell Endocrinol2011340216116721111773
   PubMed Web of Science ®Google Scholar
• PasqualiniJREstrogen sulfotransferases in breast and endometrial cancersAnn N Y Acad Sci20091155889819250196
   PubMed Web of Science ®Google Scholar
• LevinERMembrane estrogen receptors signal to determine transcription factor functionSteroids20181321429155215
   PubMed Web of Science ®Google Scholar
• ShigetaHZuoWYangNDiAugustineRTengCTThe mouse estrogen receptor-related orphan receptor alpha1:molecular cloning and estrogen responsivenessJ Mol Endocrinol19971932993099460651
   PubMed Web of Science ®Google Scholar
• SuetsugiMSuLKarlsbergKYuanYCChenSFlavone and isoflavone phytoestrogens are agonists of estrogen-related receptorsMol Cancer Res200311398199114638870
   PubMed Web of Science ®Google Scholar
• GreschikHWurtzJMSanglierSStructural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3Mol Cell20029230331311864604
   PubMed Web of Science ®Google Scholar
• RanhotraHSThe orphan estrogen-related receptor alpha and metabolic regulation: new frontiersJ Recept Signal Transduct Res201535656556826037200
   PubMed Web of Science ®Google Scholar
• ZhangLLiuPChenHCharacterization of a selective inverse agonist for estrogen related receptor alpha as a potential agent for breast cancerEur J Pharmacol201678943944827498368
   PubMed Web of Science ®Google Scholar
• ParkSChangCYSafiRERRα-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancerCell Rep201615232333527050525
   PubMed Web of Science ®Google Scholar
• WuYMChenZJLiuHInhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectinOncotarget2015628255882560126160845
   PubMedGoogle Scholar
• BernatchezGGirouxVLassalleTCarpentierACRivardNCarrierJCERRα metabolic nuclear receptor controls growth of colon cancer cellsCarcinogenesis201334102253226123720198
   PubMed Web of Science ®Google Scholar
• BonkhoffHEstrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progressionProstate201878121029094395
   PubMed Web of Science ®Google Scholar
• SunPSehouliJDenkertCExpression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor bio-markers in ovarian cancer cellsJ Mol Med (Berl)200583645746715770498
   PubMed Web of Science ®Google Scholar
• GaoMSunPWangJZhaoDWeiLExpression of estrogen receptor–related receptor isoforms and clinical significance in endometrial adenocarcinomaInt J Gynecol Cancer200616282783316681769
   PubMed Web of Science ®Google Scholar
• SunPMGaoMWeiLHAn estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cellsInt J Gynecol Cancer200616Suppl 256456817010074
   PubMedGoogle Scholar
• ChangCYKazminDJasperJSKunderRZuercherWJMcDonnellDPThe metabolic regulator ERRalpha, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancerCancer Cell201120450051022014575
   PubMed Web of Science ®Google Scholar
• DebloisGSmithHWTamISERRα mediates metabolic adaptations driving lapatinib resistance in breast cancerNat Commun201671215627402251
   PubMed Web of Science ®Google Scholar
• ThewesVSimonRSchroeterPReprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerCancer Res201575472073125643697
   PubMed Web of Science ®Google Scholar
• LuiKTamuraTMoriTZhouDChenSMCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligandsBiochem Pharmacol200876220821518550029
   PubMed Web of Science ®Google Scholar
• WuYMChenZJJiangGMZhangKSInverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathwaysOncotarget20167125681258126871469
   PubMedGoogle Scholar
• JinekMDoudnaJAA three-dimensional view of the molecular machinery of RNA interferenceNature2009457722840541219158786
   PubMed Web of Science ®Google Scholar
• ZhouHWeiJDaiQCaCO3/CaIP6 composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growthInt J Nanomedicine2015104255426626170662
   PubMed Web of Science ®Google Scholar
• BombailVGibsonDACollinsFMacPhersonSCritchleyHOSaundersPTA role for the orphan nuclear receptor estrogen-related receptor alpha in endometrial stromal cell decidualization and expression of genes implicated in energy metabolismJ Clin Endocrinol Metab20109510E224E22820668045
   PubMed Web of Science ®Google Scholar
• PekonenFNymanTRutanenEMHuman endometrial adenocarcinoma cell lines HEC 1B and KLE secrete insulin-like growth factor binding protein-1 and contain IGF-I receptorsMol Cell Endocrinol199175181871710998
   PubMed Web of Science ®Google Scholar
• Mohideen-AbdulKTazibtKBourguetMImportance of the sequence-directed DNA shape for specific binding site recognition by the estrogen-related receptorFront Endocrinol (Lausanne)2017814028676789
   PubMed Web of Science ®Google Scholar
• YangNShigetaHShiHTengCTEstrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoterJ Biol Chem199627110579558048621448
   PubMed Web of Science ®Google Scholar
• FujimotoJSatoEClinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancersJ Steroid Biochem Mol Biol20091161–2717519416752
   PubMed Web of Science ®Google Scholar
• DuYSongLZhangLThe discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancerEur J Med Chem201713645746728525844
   PubMed Web of Science ®Google Scholar
• BiancoSLanvinOTribolletVMacariCNorthSVanackerJMModulating estrogen receptor-related receptor-alpha activity inhibits cell proliferationJ Biol Chem200928435232862329219546226
   PubMed Web of Science ®Google Scholar
• RazaviPPikeMCHorn-RossPLTemplemanCBernsteinLUrsinGLong-term postmenopausal hormone therapy and endometrial cancerCancer Epidemiol Biomarkers Prev201019247548320086105
   PubMed Web of Science ®Google Scholar
• AmantFMoermanPNevenPTimmermanDVan LimbergenEVergoteIEndometrial cancerLancet2005366948449150516084259
   PubMed Web of Science ®Google Scholar
• MatsushimaHMoriTItoFAnti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancerOncotarget2016723341313414827153547
   PubMedGoogle Scholar
• SettembreCZoncuRMedinaDLA lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEBEMBO J20123151095110822343943
   PubMed Web of Science ®Google Scholar
• GhoshAJanaMModiKActivation of peroxisome proliferator-activated receptor α induces lysosomal biogenesis in brain cells: implications for lysosomal storage disordersJ Biol Chem201529016103091032425750174
   PubMed Web of Science ®Google Scholar
• Marin ZapataPABeeseCJJungerADalmassoGBradyNRHamacher-BradyATime course decomposition of cell heterogeneity in TFEB signaling states reveals homeostatic mechanisms restricting the magnitude and duration of TFEB responses to mTOR activity modulationBMC C201616355
   PubMed Web of Science ®Google Scholar
• Nsiah-SefaaABrownELRussellAPFolettaVCNew gene targets of PGC-1α and ERRα co-regulation in C2C12 myotubesMol Biol Rep201441128009801725192891
   PubMed Web of Science ®Google Scholar
• KarmakarSSeshacharyuluPLakshmananIhPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cellsOncotarget201789148061482028122356
   PubMedGoogle Scholar
• Abu-RemailehMGersonAFaragoMOct-3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/β-catenin signallingEMBO J201029193236324820736927
   PubMed Web of Science ®Google Scholar
• DingVMLingLNatarajanSYapMGCoolSMChooABFGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signalingJ Cell Physiol2010225241742820506199
   PubMed Web of Science ®Google Scholar
• ChangCYMcDonnellDPMolecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancerClin Cancer Res201218226089609523019305
   PubMed Web of Science ®Google Scholar